Veeva Reports 16% Q1 Revenue Growth, 13% Margin Rise, Mandates CRM Migration by 2030
IQV•Veeva’s Q1 FY27 revenue rose 16% to $882.9 million, led by 15% subscription growth to $730.2 million and 27 new Vault CRM customers, now over 150. The company requires Cloud clients to move to Vault by 2030; 14 of 20 biopharmas will adopt Vault CRM, and operating income climbed 13% to $395.4 million.
1. CRM Migration Mandate
Veeva is enforcing a migration of all legacy Commercial Cloud clients onto its proprietary Vault Platform by 2030. Management projects that 14 of the top 20 biopharma customers will complete the transition, creating a window for competitors to capture the remaining six, and signaling potential market share shifts.
2. Q1 FY27 Financial Performance
In Q1 FY27, Veeva generated $882.9 million in revenue, up 16% year-over-year, with subscription revenues rising 15% to $730.2 million. The company added 27 new Vault CRM customers, lifting the total to over 150, and non-GAAP operating income increased 13% to $395.4 million, maintaining robust profit margins during the platform pivot.
3. Valuation Disconnect
Veeva’s stock is trading at a forward price-to-earnings ratio below 19x, based on FY27 non-GAAP EPS guidance of about $9.05. This represents a steep decline from its three-year average forward multiple of 33x, highlighting a valuation gap driven by CRM migration risks and growth expectations.
